Sachem Capital Corp. Investing Cash Flow decreased by 159.5% to -$16.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 387.2%, from $5.75M to -$16.50M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -35.2% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$24.65M | -$58.22M | -$81.05M | -$48.44M | -$72.12M | -$30.66M | -$8.31M | -$33.96M | -$31.20M | -$2.42M | -$4.91M | $4.32M | $23.22M | $16.73M | $35.65M | $5.75M | -$8.41M | $4.25M | $27.76M | -$16.50M |
| QoQ Change | — | -136.2% | -39.2% | +40.2% | -48.9% | +57.5% | +72.9% | -308.5% | +8.1% | +92.2% | -102.9% | +188.0% | +437.5% | -27.9% | +113.1% | -83.9% | -246.3% | +150.5% | +553.7% | -159.5% |
| YoY Change | — | — | — | — | -192.6% | +47.3% | +89.7% | +29.9% | +56.7% | +92.1% | +40.9% | +112.7% | +174.4% | +791.2% | +826.2% | +33.1% | -136.2% | -74.6% | -22.1% | -387.2% |